National precision health research translation for breast and prostate cancer prevention and early detection

Project Details

Over the last decade, advances in genomic technologies and research have greatly improved our understanding of breast and prostate cancer susceptibility genes. Population-based genomic screening is urgently required to provide a more individualized and better-targeted intervention for breast and prostate cancer risk prevention, early detection, and management. This project aims to:

1. elicit Australian public and Australian research participant attitudes and preferences for population breast and prostate cancer genomic testing and the return of clinically actionable genomic information from research;
2. to assess the impact of returning clinically actionable genomic information to research participant;
3. Establish the cost-effectiveness of population screening for cancer prevention including health system impact

Project Duration

2022–2027

Researchers

• A/Prof Ilias Goranitis (Project Lead)
• Dr Cun (Lizzy) Liu
• Louise Fisher
• Daniel Sheen
• Zoe Fehlberg
• Mackenzie Bourke

Funding

NHMRC Synergy grant